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Streptomyces bacteria are gram-positive spore-forming soil
bacteria which display a complex life cycle (4, 6). Spore germination leads to vegetative growth as tangled masses of substrate mycelia on solid surfaces. Nutrient limitation triggers
production of secondary metabolites as well as growth of vertically extending aerial hyphae, which are morphologically distinct filaments that derive nutrients from the dying substrate
cell layer. Eventually, individual aerial hyphae differentiate
into chains of spores. Streptomyces mycelia growing in liquid
media display a multiphasic growth curve similar to that of
unicellular bacteria. As the culture enters stationary phase,
Streptomyces bacteria produce secondary metabolites but do
not typically differentiate morphologically (2).
Streptomyces ipomoeae is the causative agent of soil rot, the
widespread and destructive disease of sweet potatoes. The
disease results in decay of fibrous feeder roots and development of necrotic lesions on the edible storage roots (9). Prevention of soil rot currently relies solely on development of
resistant sweet potato cultivars; however, alternative approaches, including the use of biocontrol methods, are now
beginning to be investigated.
Previously, 36 strains of S. ipomoeae were divided into three
groups based on interstrain inhibition during their cocultivation on agar plates (7). The group III strains were found to
produce a diffusible 10-kDa bacteriocin-like protein (ipomicin), which is inhibitory to group I and II members and which

is stable in culture supernatants for at least 1 h at 40°C (in a pH
range of 6 to 10) (26). Sequence analyses of the ipomicin
structural gene (ipoA) and its protein product revealed that
ipomicin is initially expressed in precursor form, which upon
processing of an N-terminal signal sequence becomes the 10kDa mature form (26).
Given its potential as a biocontrol agent, we were interested
in elucidating the expression characteristics of ipomicin. It was
noted previously that TTA, the rarest codon found within the
GC-rich Streptomyces genus, is present once in ipoA within the
region that designates the ipomicin signal sequence (26). TTA
codons in Streptomyces bacteria are recognized by a single
leucyl tRNA species encoded by the gene bldA, which is required for normal morphological and physiological differentiation in these organisms (5, 14). The latter effect is due in part
to the fact that regulatory genes of antibiotic clusters and aerial
hyphae development also contain TTA codons (5). In the
model streptomycete, Streptomyces coelicolor, bldA has been
shown to be an effective growth phase regulator because it is
expressed initially in liquid and surface cultures as an inactive
precursor and, upon processing, begins to temporally accumulate as a mature tRNA, at least under certain physiological
conditions (15, 24). Interestingly, TTA-containing genes show
variation in their dependence on bldA for expression, with
some genes demonstrating strong dependence while others
show only partial or no apparent dependence (14, 23).
Here, stable ipomicin protein is shown to be temporally
produced during S. ipomoeae growth in a manner inconsistent
with ipoA mRNA levels. Similar contrary results for ipomicin
protein and ipoA mRNA concentrations were observed during
growth of the heterologous host S. coelicolor expressing a
cloned version of the S. ipomoeae ipoA gene, and this effect was
shown to be directly dependent on translation of the ipoA TTA
codon by the bldA leucyl tRNA. The data here suggest that
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Certain strains of the bacterial sweet potato pathogen Streptomyces ipomoeae produce the bacteriocin
ipomicin, which inhibits other sensitive strains of the same species. Within the signal-sequence-encoding
portion of the ipomicin structural gene ipoA exists a single rare TTA codon, which is recognized in Streptomyces
bacteria by the temporally accumulating bldA leucyl tRNA. In this study, ipomicin was shown to stably
accumulate in culture supernatants of S. ipomoeae in a growth-regulated manner that did not coincide with the
pattern of ipoA expression. Similar growth-regulated production of ipomicin in Streptomyces coelicolor containing the cloned ipoA gene was found to be directly dependent on translation of the ipoA TTA codon by the bldA
leucyl tRNA. The results here suggest that bldA-dependent translation of the S. ipomoeae ipoA gene leads to
growth-regulated production of the ipomicin precursor, which upon processing to the mature form and
secretion stably accumulates in the extracellular environment. To our knowledge, this is the first example of
bldA regulation of a bacteriocin in the streptomycetes.

regulation by bldA leads to temporal production of the ipomicin precursor, which when processed to the mature form is
secreted to the external environment, where it accumulates.
MATERIALS AND METHODS
Bacterial strains and plasmids and molecular biology methods. S. ipomoeae
strains 91-01 (group I), 88-35 (group II), 91-03, and 88-29 (group III) have been
described previously (7). S. ipomoeae spores were preserved long-term on silica
gel crystals at ⫺20°C (17) or short-term on S. ipomoeae growth agar (SIGA) (7,
8), while mycelia were grown in tryptic soy broth (TSB; Difco, Detroit, MI). S.
coelicolor strains M600 and M600⌬bldA (10) and Streptomyces lividans strain
TK23 (12) were cultured on SIGA or in yeast extract-malt extract (YEME)
medium (12). In order to obtain absorbance (600 nm) readings that accurately
reflect cell mass, aliquots of Streptomyces broth cultures were vortexed vigorously
to disperse mycelial clumps as much as possible and optical densities were
immediately determined in a spectrophotometer. The Escherichia coli host for
cloning was BRL2288 (19), while E. coli strain BL21(DE3) (22) was used to
induce expression of recombinant ipomicin protein.
All PCRs were performed using the conditions described previously (19) along
with the specific primers and templates noted below. Primers were designed by
using the Primer Design version 2 program (Scientific and Educational Software,
Cary, NC) and were synthesized by Sigma-Genosys (The Woodlands, TX). Molecular cloning was performed according to standard methods as previously
described (20). Chemical transformation of E. coli (20) and protoplast transformation of S. coelicolor (12) were performed as described elsewhere, while electroporation of E. coli BL21(DE3) was done by using a Gene Pulser II (Bio-Rad,
Hercules, CA) following the manufacturer’s instructions. Ampicillin at 50 g per
ml or kanamycin at 25 g per ml was used where appropriate to select for
plasmids in E. coli, while thiostrepton, at 50 g per ml in agar and 5 g per ml
in liquid medium, respectively, was used for selection of plasmids in S. coelicolor.
Plasmid pSIP34 was created by first amplifying a 308-bp ipoA DNA fragment
using primers ipoA-mut5⬘ (5⬘-GACGCGCCCGGCCACCCGGGC-3⬘) and
ipoA-3⬘ (5⬘-AAAAAGATCTCTGTCGCTCAGACGCGCAGG-3⬘) and the
plasmid template pSIP8 (26). The resulting fragment was digested with XbaI and
XhoI, blunt ends were generated by using the reagents in a Perfectly Blunt
cloning kit (EMD Chemicals, Inc., Gibbstown, NJ), and the blunt-ended fragment was then ligated to EcoRV-digested pET30a⫹ vector (EMD Chemicals,
Inc.). The resulting clone, pSIP34, contains the portion of the ipoA open reading
frame that encodes the mature form of ipomicin cloned in frame with the
pET30a⫹ His-Tag leader sequence. To construct plasmid pSIP40, pSIP8 was
partially digested with PstI, and the linearized full-length 3.3-kb fragment was
cloned into the streptomycete vector pIJ350 (13) at this same site.
The TTA codon in the ipoA gene was converted to CTC by a modification of
the two-stage PCR overlap extension method described previously (11). Briefly,
in the first stage the template was pSIP8 in both PCRs, and, in one reaction, an
0.6-kb fragment was amplified with universal SP6 primer (New England Biolabs,
Ipswich, MA) and a mutagenic primer containing the desired mutation, ipo-leuCTC (5⬘-GCCTCCGCCCTCCGCGCCGT-3⬘), while in the other reaction, an
0.4-kb overlapping fragment was amplified by using universal T7 primer (New
England Biolabs) and primer ipo-2cycle-2 (5⬘-TGCCCGGGTGGCCGGGCGC
G-3⬘). The two PCR products were combined, denatured, and allowed to reanneal; Pfu polymerase (Stratagene, La Jolla, CA) and nucleotides were added, and
six cycles of PCR were performed in order to fill in the available recessed 3⬘ ends.
The resulting double-stranded DNA was then used as a template in a 15-cycle
PCR using the universal SP6 and T7 primers. The resulting 0.9-kb product was
digested with XhoI and EcoRI and ligated to the E. coli cloning vector pSP72
(Promega Corp., Madison, WI) at these sites, and the resulting recombinant
clones were sequenced to identify those which contained the TTA-to-CTC codon
change. One of these was digested with XbaI and EcoRI, and the 0.9-kb fragment generated was used to replace the same-size fragment containing the
wild-type ipoA gene in pSIP40, with the resulting clone being designated pSIP42.
Plasmid pGSP149 has been described previously (18).
Plate bioassays. Aliquots of S. ipomoeae TSB cultures shaken at 30°C were
harvested by centrifugation. The resulting supernatants were filtered through an
0.2-m filter to remove remaining mycelia and stored at ⫺20°C. Plate bioassays
were performed by modification of a previously described method (26). Briefly,
for each time point 5 l of undiluted culture supernatant and 5 l of a 10-fold
dilution of supernatant in 20 mM sodium phosphate buffer (pH 7.0) were spotted
onto SIGA, which had been freshly inoculated with a dense spore suspension of
strain 91-01 or strain 88-35. Following incubation at 30°C for 3 days, the resulting
zones of inhibition were measured. The diameter of the inhibition zone of
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undiluted supernatant was the measurement used when a 10-fold dilution of the
supernatant did not produce an inhibition zone of at least 4 mm in diameter.
When a 10-fold dilution did produce a zone of at least 4 mm, then the measurement used was that diameter multiplied by 10 (i.e., the “adjusted diameter”).
Thus, inhibition zone diameters of greater than or equal to ⬃40 mm given in the
text were the adjusted diameters for those time points. Dilutions of 100-fold were
also initially tested but were never found to produce zones of at least 4 mm. The
4-mm-diameter cutoff was chosen because inhibition zones smaller than this
could not always be accurately distinguished within the lawns of test strains.
Ipomicin stability assay. To measure the stability of ipomicin, a 25-ml culture
of strain 91-03 was grown to stationary phase, and the supernatant was purified
by centrifugation and filtration as described above. The cell-free supernatant was
then incubated at 30°C with shaking at 300 rpm, and aliquots were removed at
every 24-hour point up to 7 days; following storage at ⫺20°C where necessary till
the end of the assay, all aliquots were then examined for inhibition activity
against strain 91-01 by plate bioassay.
RNA methods. RNA was isolated by using modified Kirby mixture, phenolchloroform extraction, and treatment with DNase I as described previously (12).
For Northern blot analysis, 10-g (or, for some experiments, 30-g) samples of
total RNA, along with a single-stranded RNA ladder (New England Biolabs),
were electrophoresed overnight at 20 V on 1% agarose gels containing formaldehyde (20) and were then blotted to a Hybond N nylon membrane (Amersham
Pharmacia Biotech, Piscataway, NJ) using the VacuGene XL vacuum blotting
system (Amersham Pharmacia Biotech). RNA was cross-linked to membranes by
using UV light. Radiolabeled probes were generated by random priming (21)
using the 0.9-kb HindIII-BglII fragment of pSIP8 as template for the ipoA probe
or a 16S rRNA fragment, which had been generated by PCR using relevant
genomic DNA and primers described previously (25), as a template for the 16S
rRNA probe. Hybridizations were performed as previously described (1).
Generation of ipomicin antiserum and Western blot analysis. Induction of an
ipomicin fusion protein in E. coli BL21 containing plasmid pSIP34, followed by
cell fractionation and preparative sodium dodecyl sulfate-polyacrylamide gel
electrophoresis, was performed as described previously (19). A fusion protein
band with a molecular mass of ⬃16 kDa was excised from the gel and was used
as antigen to raise antibodies in a rabbit (as performed by Animal Pharm
Services, Inc. [Healdburg, CA]).
To prepare protein samples for Western blotting, secreted ipomicin proteins
were precipitated from cell-free supernatants of relevant S. ipomoeae or S.
coelicolor cultures with trichloroacetic acid. To a 1-ml aliquot of supernatant,
bovine serum albumin was added to 0.1 mg per ml, trichloroacetic acid was then
added to 10% (wt/vol), and the mixtures were incubated on ice for 30 min,
followed by centrifugation at 13,200 rpm for 15 min at 4°C. Pellets were washed
with 1 ml acetone and incubated at room temperature for 10 min, and the protein
precipitates were then pelleted by centrifugation as described above, dried on
ice, and resuspended in 50 l distilled water. The protein concentration of each
sample was determined by using a Bio-Rad protein assay according to the
manufacturer’s protocol. Western blotting was performed as previously described (19), except that 10-g protein samples were electrophoresed on 18%
sodium dodecyl sulfate-polyacrylamide gels and upon blotting were probed with
a 1:1,000 dilution of the primary antiserum. The intensity of bands on digital
images of Western or Northern blots was analyzed by using ImageJ (http://rsb
.info.nih.gov/ij/index.html). A given band intensity was calculated as the product
of the selected pixel area and the mean gray value for those pixels, and the
average band intensity from three such measurements, along with the associated
standard deviation, was reported for each band.

RESULTS AND DISCUSSION
Growth-regulated ipomicin production in S. ipomoeae. The
kinetics of ipomicin inhibitor production during growth of S.
ipomoeae strain 91-03 were examined by using a plate bioassay
(see Materials and Methods for more details). Initially, as
shown in Fig. 1A, the diameter of inhibition zones seen in plate
bioassays changed very little during the first four time points
despite the fact that the absorbance (600 nm) of the culture
increased over fourfold from 0.13 at the first time point to 0.58
by the fourth time point. By the fifth time point, however,
inhibition zone size began to increase significantly by over
fourfold from the previous level (i.e., from 10.7 mm in diameter to 43.3 mm [adjusted diameter]), while the culture density
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FIG. 1. Growth-regulated appearance of ipomicin during culturing of S. ipomoeae strain 91-03 as determined by plate bioassay and Western
blotting. (A) Growth curve of strain 91-03 and measurement of bioassay inhibition zones. Spores of S. ipomoeae strain 91-03 (group III) were
inoculated into TSB and incubated at 30°C while shaking. At time points throughout growth, aliquots were used either to measure the culture
absorbance at 600 nm (f) or to test for inhibitor function present in the culture supernatant by the plate bioassay method (䡺) as described in
Materials and Methods. The data presented are one of six biological replicates that were performed with approximately the same results occurring
in each case. Within the one biological replicate shown, there were three independent experimental trials for measurement of ipomicin activity at
each time point; the activity results presented are the average diameter or average adjusted diameter of inhibition zones seen in plate bioassays
for those three replicates, with the error bars representing the associated standard deviations. The lack of a discernible error bar for a particular
time point indicates that there was little or no deviation in diameter or adjusted diameter among the three replicates. (B) Western blots of ipomicin
protein. At the same time points as those used for panel A, proteins were precipitated from cell-free supernatant, and 10-g aliquots were analyzed
by Western blotting. The negative control (i.e., the lane marked with a minus sign) was the cell-free supernatant of a culture of S. lividans strain
TK23 grown to stationary phase, while the positive control (i.e., the lane marked with a plus sign) was ipomicin protein as contained in purification
fraction IV (26). The data presented are one of three biological replicates with approximately the same results obtained in each case. OD600, optical
density at 600 nm. (C) ImageJ analysis of the Western blot shown in panel B. Band intensities (in gray values [g.v.]) on the digital image of the
Western blot were determined in triplicate with the average intensity being reported for each band along with the associated standard deviation
(error bars). The lack of a discernible error bar for a particular time point indicates that there was little or no deviation among the three
determinations.

increased only from 0.58 to 0.71. For the remainder of exponential phase, inhibition zones showed a fairly steady increase
in adjusted diameter, whereupon their sizes appeared to level
off upon entrance of the culture into stationary phase.
To correlate bioassay results with the presence of the 10kDa ipomicin protein, culture supernatant at the identical time

points used for bioassays was analyzed by Western blotting
using an antiserum specific for ipomicin protein (Fig. 1B; see
Materials and Methods for details). There was good correlation between the size of inhibition zones seen in plate bioassays
(Fig. 1A) and the temporal appearance of the 10-kDa ipomicin
protein in culture supernatants (Fig. 1B). Measurement of
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band intensities in Western blots using ImageJ (http://rsb.info
.nih.gov/ij/index.html), for example, revealed that ipomicin
concentration increased approximately 4.3-fold from the
fourth to the fifth time point (Fig. 1C), which was in agreement
with the change in size of plate bioassay inhibition zones observed over that same time frame.
To address the possibility that growth-regulated ipomicin
production was somehow unique to strain 91-03, we performed
the same plate bioassay and Western blot analyses on another
group III strain (88-29), which was isolated from a geographic
location separate from that of 91-03 and which showed other
significant phenotypic and genotypic differences (7). Congruent temporal patterns of ipomicin inhibition as determined by
plate bioassay and ipomicin protein expression were also observed for strain 88-29, with the only significant difference from
91-03 being that relatively more ipomicin inhibitor appeared to
be present at each corresponding time point during growth of
88-29 (data not shown). Overall, these results suggest that a
common mechanism of growth-regulated ipomicin production
and/or accumulation exists in S. ipomoeae group III strains.
Evidence of a posttranscriptional control mechanism. To
investigate whether the growth-regulated appearance of ipomicin was controlled at the transcriptional level, the expression
pattern of ipoA mRNA was examined by Northern blotting at
select identical time points used for bioassays and Western
blotting (i.e., time points 2, 5, 9, and 11 from Fig. 1). A hybridized band of approximately 500 nucleotides was detected
for the S. ipomoeae 91-03 samples (Fig. 2A), which, based on
its size, represents a single monocistronic mRNA species for
the 393-bp ipoA open reading frame (26). As expected, the
probe did not hybridize to S. lividans strain TK23 total RNA
(Fig. 2A).
Unlike the results for ipomicin function and expression,
ipoA message did not increase in a temporally regulated manner (Fig. 2A and B). At the earliest time point analyzed by
Northern blotting (absorbance [600 nm] equal to 0.22), the
concentration of ipoA mRNA was greater than or equal to the
amount seen at the next time point analyzed (absorbance [600
nm] equal to 0.71). As seen in Fig. 1, not only was ipomicin at
or near its lowest observed concentration when the culture
density measured 0.22, but the protein also did not begin to
increase in amount until more than 6.5 h later (i.e., after the
fourth time when the culture density measured 0.58). The lack
of correlation between intracellular ipoA mRNA concentration
and active ipomicin protein in culture supernatants suggested
that ipomicin production is regulated posttranscriptionally and
raised the possibility that bldA regulation dictates temporal
production of ipomicin.
Ipomicin production in the heterologous host S. coelicolor is
growth regulated and dependent on bldA. As further analysis of
bldA control of ipomicin production in S. ipomoeae was not
practical due to a current lack of a system for genetic manipulation in this organism, it was next determined whether the
10-kDa ipomicin protein shows growth-regulated expression in
the heterologous host S. coelicolor, which was previously shown
to be ipomicin resistant (26). Supernatant from culture time
points (Fig. 3A) of the wild-type strain M600 containing plasmid pSIP40, a thiostrepton-resistant plasmid containing a
cloned version of the S. ipomoeae ipoA gene, was examined as
before by Western blotting (Fig. 3B), and the results were
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FIG. 2. Northern blot of the ipoA message in S. ipomoeae 91-03.
(A) For some of the identical time points used in Fig. 1 (i.e., time
points 2, 5, 9, and 11), total RNA was harvested from mycelia of S.
ipomoeae strain 91-03, as well as S. lividans TK23 grown to stationary
phase, and approximately equivalent amounts were subjected to
Northern blotting analysis using a 32P-labeled probe specific for the
ipoA or 16S rRNA gene. Finished blots were visualized by autoradiography. Three biological replicates of the ipoA experiment were performed with similar results in each case. OD600, optical density at 600
nm. (B) ImageJ analysis of the Northern blots shown in panel A.
ImageJ analysis was performed as described in the legend to Fig. 1.
g.v., gray values.

consistent with the notion that ipomicin production in S. coelicolor M600(pSIP40) is growth regulated, with the overall pattern appearing very reminiscent of that seen in S. ipomoeae. An
analysis of ipoA mRNA concentration in strain M600 containing pSIP40 at the identical time points used for Western blotting showed constitutive expression of the ⬃500-nucleotide
ipoA message (data not shown), a result which confirmed that
temporal production of ipomicin is also posttranscriptionally
controlled in the heterologous host S. coelicolor.
When the isogenic S. coelicolor bldA-null mutant M600⌬
bldA containing pSIP40 was grown similarly (Fig. 3A) and then
analyzed by Western blotting, ipomicin appeared in the culture
supernatant in a weak yet temporal manner (Fig. 3B). As
equivalent amounts of total protein were analyzed in the Western blot assays for M600(pSIP40) and M600⌬bldA(pSIP40),
the results demonstrated a strong dependence on bldA for
ipomicin production, though relatively weak mistranslation of
the ipoA message was also apparently occurring. The temporal
appearance of ipomicin in strain M600⌬bldA(pSIP40) also suggested that an additional posttranscriptional mechanism(s) was
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FIG. 3. Temporal appearance of ipomicin protein as produced by
S. coelicolor strains M600 and M600⌬bldA containing the cloned ipoA
gene. (A) Growth curves of S. coelicolor M600 (f) and M600⌬bldA
(䡺) each containing plasmid pSIP40. Spores of M600(pSIP40) or
mycelia of M600⌬bldA(pSIP40) were inoculated into YEME containing thiostrepton, and these cultures were then incubated at 30°C while
shaking. At time points throughout growth, aliquots were used to
determine the culture absorbance at 600 nm. (B) Western blots of the
10-kDa ipomicin products as produced by pSIP40-containing M600
versus M600⌬bldA. At several of the same time points as those used in
panel A, proteins were precipitated from aliquots of cell-free supernatant and analyzed by Western blotting. Precipitated proteins from
the supernatants of M600(pGSP149) and M600⌬bldA(pGSP149) cultures grown similarly to stationary phase were included as negative
controls. OD600, optical density at 600 nm. The data shown in panels
A and B are one of three biological replicates for each strain, with
similar results being obtained in each case.

contributing to growth-regulated production and/or accumulation of ipomicin.
To determine whether the reduced yield of ipomicin protein
produced by the S. coelicolor bldA mutant was due specifically
to the inability to properly translate the TTA codon in ipoA,
this codon position in the gene was changed to CTC, an alternate leucine codon whose cognate tRNA appears constitutively throughout Streptomyces growth in contrast to the temporal appearance of the bldA tRNA (24). A comparison by
Western blotting and subsequent ImageJ analysis at single
exponential and stationary time points for strain M600⌬bldA
containing either pSIP40 (wild-type ipoA gene) or pSIP42
(ipoA with TTA-to-CTC codon change) showed increased concentrations of ipomicin in the culture supernatant during both
exponential (9-fold more) and stationary (4.5-fold more)

APPL. ENVIRON. MICROBIOL.

FIG. 4. Western blot of ipomicin protein and concomitant Northern blot of ipoA message for S. coelicolor M600⌬bldA containing plasmid pSIP40 versus pSIP42. (A) Western blot of ipomicin protein.
Mycelia of M600⌬bldA(pSIP40) and M600⌬bldA(pSIP42) were inoculated into YEME containing thiostrepton and incubated at 30°C with
shaking, and at single time points indicative of exponential- and stationary-phase growth, proteins were precipitated from aliquots of cellfree supernatant and analyzed by Western blotting. Precipitated protein from the supernatant of an M600⌬bldA(pGSP149) culture grown
similarly to stationary phase was included as a negative control. The
experiment shown was one of three biological replicates, with approximately the same results being obtained in each case. (B) Northern blot
of ipoA message. At the identical time points as those used in panel A,
total RNA was isolated and subjected to Northern blotting as described in the legend to Fig. 2. The ipoA data are derived from a single
blot; however, the M600⌬bldA(pSIP40) side was subjected to autoradiography for 1 h, versus 4 h for the M600⌬bldA(pSIP42) portion.
OD600, optical density at 600 nm.

phases for M600⌬bldA (pSIP42) compared to the control (Fig.
4A). Moreover, the amount of ipomicin protein released by
pSIP42-containing cells at the exponential time point actually
appeared to exceed the amount released by cells containing
pSIP40 during stationary phase. These results contrasted dramatically with concomitant Northern blotting of ipoA where,
for reasons undetermined, the concentration of ipoA in M600⌬
bldA (pSIP40) far exceeded that for M600⌬bldA (pSIP42) (Fig.
4B). Taken together, these data thus support a mechanism by
which bldA is needed for efficient translation of the TTA codon
of the cloned ipoA gene in S. coelicolor. Given the observation
of posttranscriptional control for ipomicin production in both
S. ipomoeae and S. coelicolor along with evidence of a conserved mechanism of bldA regulation throughout the Streptomyces genus (i.e., nonrandom distribution of TTA codons and
similarity of bldA mutant phenotypes among species) (3), it
seems likely that bldA control similarly regulates production of
ipomicin in the natural S. ipomoeae host. Confirmation of this
assertion awaits development of a system for the genetic manipulation of S. ipomoeae.
Stability of ipomicin under extended incubation conditions.
Given the temporal appearance of ipomicin even in the S.
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FIG. 5. Ipomicin stability assay. (A) Plate bioassay of stability assay
time points. Cell-free supernatant from an S. ipomoeae strain 91-03
stationary-phase culture was incubated at 30°C while shaking for a
total of 7 days. At every 24-h time point, an aliquot was removed and
stored at ⫺20°C days until the 7-day incubation period was completed,
and the aliquots were then tested for inhibitory activity by the plate
bioassay as described in Materials and Methods. The data presented
are one of three biological replicates that were performed, with approximately the same results occurring in each case. Within the one
biological replicate shown, three independent experimental trials for
determination of ipomicin activity at each time point were performed;
the activity results presented are the average diameter or average
adjusted diameter of inhibition zones seen in plate bioassays for those
three replicates, with the error bars indicating standard deviations. The
lack of a discernible error bar for a particular time point indicates that
there was little or no deviation in diameter or adjusted diameter
among the three replicates. (B) Western blot of stability assay time
points. At the same time points as those used in panel A, proteins were
precipitated and analyzed by Western blotting. The negative control
was the cell-free supernatant of a culture of S. lividans strain TK23
grown to stationary phase.

coelicolor bldA-null mutant containing plasmid pSIP40 (or
pSIP42), it was next determined whether the apparent stability
of ipomicin noted previously (26) may contribute to its pattern
of appearance seen here. Filtered supernatant from a stationary-phase culture of S. ipomoeae strain 91-03 was subjected to
extended incubation at 30°C with daily assessment of ipomicin
inhibition function by the plate bioassay method. No significant
difference in inhibition zone size was observed after 24 h of
incubation, while an approximately 50% reduction in adjusted
diameter occurred after 48 h (Fig. 5A). At 72 h and beyond,
inhibition zones were greatly diminished in size or were absent,
indicating that little or no ipomicin inhibitory activity remained. An analysis of the ipomicin protein at these same time
points by Western blotting showed no change in concentration
of the protein during the 7-day incubation of the supernatant
(Fig. 5B); this finding indicated that inactivation rather than
degradation of ipomicin was responsible for the loss of activity
observed in the assay. Although the results here may not be
entirely representative of the pattern of ipomicin inactivation/
degradation in an actively growing culture, they are nevertheless consistent with the notion that active ipomicin protein
stably accumulates during growth of S. ipomoeae and that such
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an effect is likely to contribute to the temporal appearance of
ipomicin in culture supernatants. This stability data may also
have important implications for the potential use of ipomicin
as a biological agent for preventing infection of sweet potatoes
by S. ipomoeae.
TTA-containing Streptomyces genes are typically species specific and apparently nonessential in function and often show evidence of relatively recent lateral transmission (3, 16). The possible origin of the ipomicin structural gene ipoA in S. ipomoeae and
the mechanism of action of ipomicin currently remain unknown,
and no homologs exist for either in the databases. Nevertheless,
bldA translational control of the single TTA codon in ipoA was
shown here to contribute greatly to the temporal pattern of
ipomicin production seen in S. coelicolor, and it was very likely the
basis for the analogous pattern of production seen in the native
host S. ipomoeae. To our knowledge, ipomicin is the first Streptomyces bacteriocin shown to be dependent on bldA for its expression. Moreover, the results with S. coelicolor showed that
bldA regulation of ipomicin expression occurs upon introduction
of the single TTA-containing ipoA gene into a heterologous host.
This situation, which has implications for potential lateral transmission of ipoA, thus contrasts with typical bldA control of antibiotic production in Streptomyces spp. where TTA codons reside
in key regulatory genes (5).
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